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Low-grade ﬁbromyxoid sarcoma (LGFMS) is an extremely rare neoplasm classiﬁed as a ﬁbroblastic soft
tissue tumor. It has been described by its characteristic deceptively benign histological appearance with
metastatic potential during long-term follow-up. We herein describe an 8-year-old boy with LGFMS
located in the internal oblique muscle. Histological ﬁndings of the resected specimen included con-
trasting ﬁbrous and myxoid areas with a swirling, whorled growth pattern; bland, benign-appearing
ﬁbroblastic spindle cells; and large collagen rosettes. Immunohistologic examination revealed mucin 4
positivity. The surgical margin of the tumor was obscure; therefore, we performed an additional
resection 2 months later with a 1 cm margin from the edge of the tumor. No recurrence or metastasis
was identiﬁed throughout 1 year of follow-up.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Low-grade ﬁbromyxoid sarcoma (LGFMS) is an uncommon
deep soft tissue neoplasm usually found in the lower limbs,
trunk, upper limbs, buttocks, head, and neck. It typically occurs in
young to middle-aged adults, but is sometimes found in children.
LGFMS has a deceptively benign histological appearance with
malignant potential, and long-term follow-up has indicated high
rates of local recurrence and eventual metastasis. We herein
report a rare case of LGFMS in the internal oblique muscle of an
8-year-old boy.1. Case report
An 8-year-old boy had a 2-year history of a rapidly growing
abdominal mass in the right abdominal wall. He had no associated
pain, distention, rebound, or guarding of the abdomen. The mass
measured 4.0  3.7  3.0 cm, and magnetic resonance imaging
showed a low-intensity area on T1-weighted images and a partially
high-intensity area on T2-weighted images (Fig. 1). We performed
surgical excision of the tumor. The tumor was located in theery, Department of Surgery,
Osaka 573-1191, Japan.
kaguchi).
Inc. This is an open access article uinternal oblique muscle, and its surface was smooth and grayish
white (Fig. 2). The postoperative course was uneventful, and the
patient was discharged after 7 days.
Histologically, the tumor consisted of contrasting ﬁbrous and
myxoid areas with a swirling, whorled growth pattern; bland,
benign-appearing ﬁbroblastic spindle cells; and large collagen ro-
settes (Fig. 3). The surgical margin of the tumor was obscure.
Immunohistochemical examination revealed positivity for mucin 4
(MUC4) and epithelial membrane antigen (Fig. 4). The pathological
diagnosis was LGFMS.
As the lesion had a marginal excision, 2 months later, we per-
formed an additional wide resection to remove a margin 1 cm
from the border of the previous resection. No tumor remnant was
found in the additional specimen. No local recurrence or metas-
tasis was identiﬁed by lung computed tomography 1 year after
surgery.2. Discussion
LGFMS was ﬁrst described in 1987 [1] as a deceptively
benign-appearing, unclassiﬁable but very similar ﬁbromyxoid
sarcomas characterized histologically by bland, innocuous-
appearing ﬁbroblastic cells and a swirling, whorled growth
pattern were presented. The reported incidence of LGFMS wasnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Magnetic resonance images demonstrate a large tumor exhibiting partial hyperintensity on T2-weighted images and low signal intensity on T1-weighted images.
Fig. 3. Microscopic examination revealed a whorled growth pattern with bland
spindle-shaped tumor cells.
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soft tissue sarcomas [2]. Tang et al. [3] reported the largest
literature review of 273 cases of LGFMS, including 136 females
and 137 males. Notably, the median onset age was 35 years, and
35 cases (13%) occurred in patients aged <18 years. Tumors were
commonly located in the lower limbs, trunk, upper limbs, but-
tocks, head, and neck [3]. High rates of local recurrence and
distant metastasis reported by several investigators are shown
in Table 1. Their results varied widely; the local recurrence rate
ranged from 9% to 73%, and the metastasis rate ranged from 6%
to 45%. Folpe et al. [4] considered that earlier studies might have
overstated the aggressive potential of LGFMS because of the
presence of a larger group of patients with undiagnosed LGFMS
who had never had a subsequent adverse event and who
therefore had not been identiﬁed. It has also been argued that
the insufﬁcient length of follow-up has not allowed for complete
assessment of the behavior of LGFMS. Local recurrence may
reportedly develop up to 15 years later, and distant metastasis
may occur 45 years later [8]; however, most investigators have
described cases that they followed for <1 year. Furthermore,
incompleteness of the excisional margin is a risk factor for
recurrence and metastasis. Folpe et al. [4] performed an addi-
tional wide excision in 35 cases (69%) when the original surgical
margin was not ascertained to be negative, whereas some case
series included marginally positive cases without additional
treatment. Most LGFMSs are deceptively well circumscribed but
not encapsulated, and resection is often incomplete. Complete
surgical excision with a safety margin is the mainstay of treat-
ment for patients with LGFMS. The role of radiotherapy and
chemotherapy remains controversial.
Histologically, LGFMS consists of bland ﬁbroblasts with a
whorled or linear arrangement alternating with less cellular areasFig. 2. Macroscopically, the tumor was solid with a grayish-white cut surface.
Fig. 4. Tumor cells showed diffuse and strong immunoreactivity for MUC4.with a myxoid stroma [9]. Approximately 40% of LGFMSs show
focal poorly formed collagen rosettes [10]. Diagnosis of LGFMS is
less difﬁcult when distinctive hyalinized collagen rosettes are
encountered. The differential diagnoses of LGFMS include des-
moid-type ﬁbromatosis, nodular fasciitis, soft tissue perineur-
ioma, neuroﬁbroma, dermatoﬁbrosarcoma protuberance, and
Table 1
Reported clinical features and prognosis of LGFMS.
Author Year Type of study Cases (males/females) Age (years)
Range [median]
Location (number) Size (cm)
Range [median]
Follow up duration
(months)
Range [median]
Local recurrence (%) Metastasis (%) Death from disease (%)
Folpe [4] 2000 Case series 73 (40/33) 3e78
[34]
Lower limbs (30)
Trunk (21)
Upper limbs (11)
Buttock (7)
Head/neck (4)
1e23
[4.5]
[24] 9 6 2
Antonescu [5] 2004 Case series 15 (6/9) 27e81
[61]
Upper limbs (7)
Lower limbs (4)
Neck (2)
Chest wall (1)
Buttock (1)
ND 27e117
[50]
73 13 7
Mertens [6] 2005 Case series 23 (12/11) 12e75
[34]
Lower limbs (11)
Buttock (4)
Head/neck (3)
Trunk (3)
Upper limbs (1)
Retroperitoneum (1)
3e18
[7]
1e324
[64]
43 26 0
Guillou [7] 2007 Case series 63 (24/39) 11e75
[35]
Lower limbs (28)
Trunk (23)
Upper limbs (5)
Hip (4)
Neck (3)
1e20
[6]
3e290
[16]
11 13 0
Tang [3] 2010 Literature review 273 (137/136) 1.8e75
[35]
Lower limbs (113)
Trunk (58)
Upper limbs (42)
Internal organs (40)
Head/neck (17)
1e27
[6]
2e600
[44]
29 18 3
Evans [8] 2011 Case series 33 (19/14) 6e52
[29]
Lower limbs (10)
Upper limbs (6)
Trunk (6)
Intraperitoneal (4)
Head/neck (3)
Buttok (3)
Retroperitoneum (1)
1.5e16
[9.4]
36e378
[156]
65 45 44
Maretty-Nielsen [2] 2013 Case series 14 (5/9) 8e65
[36]
Buttock (4)
Trunk (3)
Upper limbs (3)
Lower limbs (2)
Head/neck (2)
2e26
[4.5]
30e292
[60]
29 21 0
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soft tissue perineurioma are the closest histologic mimics of
LGFMS; however, they usually lack the whorled growth pattern
that is characteristic of LGFMS [11]. Lane et al. [12] reported a
variant of LGFMS termed hyalinizing spindle cell tumor with giant
rosettes (HSCT); this is now accepted as a subtype of LGFMS.
Doyle et al. [13] reported that MUC4 is a highly sensitive and
speciﬁc immunohistochemical marker for LGFMS. MUC4 is a
useful marker for identifying various soft tissue tumors including
sclerosing epithelioid ﬁbrosarcoma (SEF) [14], which is considered
to exhibit morphologic and genetic overlap with LGFMS. Some
cases of HSCT appear to have hybrid features between SEF and
LGFMS. Most LGFMSs are characterized by FUSeCREB3L1,
FUSeCREB3L2, or EWSR1eCREB3L1 gene fusions [15]. The tumor-
speciﬁc fusion gene can be detected by reverse-transcription
polymerase chain reaction using formalin-ﬁxed, parafﬁn-
embedded tissue and by ﬂuorescence in situ hybridization [10].
Detection of these genomic changes can be a reliable method with
which to accurately diagnose LGFMS.
We decided to perform an additional wide excision of the tumor
because of the possibility of a tumor remnant and its malignant
potential. As the lesion had a marginal excision, an additional wider
local excision has been recommended [4,16]. The histological
diagnosis was deﬁnitive based on the typical microscopic ﬁndings
and MUC4 positivity, and genetic analysis was not required.3. Conclusions
LGFMS has a deceptively benign appearance; however, it tends
to be excised incompletely and affected patients tend to become
lost to long-term follow-up. Clinicians should be aware of the na-
ture of this rare disease, which sometimes occurs in children. MUC4
is a quite useful immunohistological marker for diagnosis. Genomic
exploration may be preferable when the diagnosis is difﬁcult.
Although the usefulness of additional wide excision of the tumor is
unclear, there seems to be a consensus that additional excision is
preferable when the surgical margin obtained during the ﬁrst
operation is obscure.
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